HR 8013 · 116th Congress 2019–2021, ended

End Taxpayer Funding of Gender Experimentation Act of 2020

Fact sheet

Latest action · Aug 11, 2020 Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedAug 11, 2020
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

End Taxpayer Funding of Gender Experimentation Act of 2020

This bill modifies provisions relating to federal funding for, and health insurance coverage of, gender reassignment medical interventions, which include surgical remedies and hormone therapy arising from a conflict between an individual's gender identity and the sex the individual has or was identified as having at birth. Specifically, the bill prohibits the use of federal funds for gender reassignment medical interventions or for health coverage that includes such interventions. Additionally, such interventions may not be provided in a federal health care facility or by a federal employee. Under current law, coverage of these interventions through Medicare and Medicaid is generally determined at the state level.

The bill's restrictions regarding the use of federal funds do not apply to treatment of individuals with medically verifiable disorders of sex development, such as individuals born with atypical development of chromosomal, gonadal, or anatomical sex.

The bill also prohibits qualified health plans from including coverage for gender reassignment medical interventions. Further, plans that include coverage for such interventions are not eligible for federal subsidies.

Cosponsors 12

Members who signed on, in the order they did. Signatures ran from Aug 11, 2020 to Sep 30, 2020, with 9 there on the day it was introduced.

SeatCosponsorSigned on
R-TXBill FloresOriginalAug 11, 2020
R-TXBrian BabinOriginalAug 11, 2020
R-CODoug LambornOriginalAug 11, 2020
R-GAJody B. HiceOriginalAug 11, 2020
R-SCRalph NormanOriginalAug 11, 2020
R-GARick W. AllenOriginalAug 11, 2020
R-ALRobert B. AderholtOriginalAug 11, 2020
R-IASteve KingOriginalAug 11, 2020
R-FLW. Gregory SteubeOriginalAug 11, 2020
R-AZDebbie LeskoAug 21, 2020
R-WIGlenn GrothmanSep 15, 2020
R-KSRoger MarshallSep 30, 2020

Actions 2

Everything that happened, newest first.

  1. Aug 11, 2020Introduced in House
  2. Aug 11, 2020Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Aug 11, 2020Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.